Role of Heparan Sulfate-Degrading Sulfatases in Pancreatic Adenocarcinomas

硫酸乙酰肝素降解硫酸酯酶在胰腺腺癌中的作用

• 批准号: 7128287
• 负责人: STEVEN D ROSEN
• 金额: $ 11.67万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-01 至 2008-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7128287
• 关键词: adenocarcinoma; cell line; enzymes; heparan sulfate; human; motivation; neoplasm /cancer; proteins; reduction; role; stem cells; sulfatases; sulfation

DESCRIPTION (provided by applicant): Pancreatic adenocarcinoma is one of the most deadly malignancies in human for which there are very limited treatment options. There is great interest in the possible role of embryonic signaling pathways in the initiation and progression of this cancer and others. Among these pathways is canonical Wnt signaling, which is involved in the proliferation and self-renewal of stem/progenitor cells and has been speculated to have a similar role in cancer stem cells. The presence of activated beta-catenin in pancreatic tumor samples suggests that 30-40% of these tumors manifest Wnt signaling. Moreover, Matthias Hebrok and colleagues at UCSF have discovered that active Wnt signaling is required for the growth of several pancreatic adenocarcinoma cell lines in vitro. Our exploratory R21 project proposes to investigate the role of two novel sulfatases, called HSulf-1 and HSulf-2, in Wnt signaling within pancreatic adenocarcinomas and their contributions to the growth and tumorigenicity of these cancer cells. The Sulfs are extracellular enzymes which act on heparan sulfate proteoglycans (HSPGs) to remove a specific sulfation modification (glucosamine-6-O-sulfation). One known biological activity of the Sulfs is to modulate the interaction of Wnt ligands with HSPGs and to potentiate the ability of the Wnts to activate their signal transduction receptors. Our preliminary studies have found the expression of SULF1 or SULF2 transcripts in 23 of 24 pancreatic adenocarcinoma cell lines and the presence of Sulf-1 or Sulf-2 protein in 4/4 of these cell lines and 3/5 of pancreatic tumor samples. Expression of a dominant negative form (enzymatically-inactive mutant) of either Sulf-1 or Sulf-2 in 3 out of 4 of these lines resulted a reduction in Wnt signaling. Furthermore, co-culturing the same three cell lines in the presence of inactive Sulf protein produced a parallel reduction in Wnt signaling and cell growth in vitro. The proposed research will employ lentivirus-transduced shRNA expression to silence one or both Sulfs in representative pancreatic adenocarcinoma cell lines. Our Aims are: 1) To determine the effects of Sulf silencing on the growth and Wnt signaling of these cells in vitro; and 2) To determine the effects of Sulf silencing on the ability of the cells to form tumors in nude mice. Positive results from these studies should stimulate considerable interest in the Sulfs as possible targets (for small molecules or function-blocking antibodies) for the treatment of pancreatic adenocarcinoma in humans.

描述（由申请人提供）：胰腺腺癌是人类最致命的恶性肿瘤之一，治疗方案非常有限。胚胎信号通路在这种癌症和其他癌症的发生和发展中的可能作用引起了极大的兴趣。在这些途径中，典型的Wnt信号通路参与了干细胞/祖细胞的增殖和自我更新，并被推测在癌症干细胞中具有类似的作用。胰腺肿瘤样本中活化β -连环蛋白的存在表明，30-40%的肿瘤表现出Wnt信号。此外，加州大学旧金山分校的Matthias Hebrok及其同事发现，几种胰腺腺癌细胞系的体外生长需要活跃的Wnt信号。我们的探索性R21项目旨在研究两种新型磺化酶HSulf-1和HSulf-2在胰腺腺癌Wnt信号传导中的作用及其对这些癌细胞生长和致瘤性的贡献。硫是细胞外酶，作用于硫酸肝素蛋白聚糖（HSPGs）以去除特定的磺化修饰（氨基葡萄糖-6- o -磺化）。Sulfs的一个已知生物活性是调节Wnt配体与HSPGs的相互作用，并增强Wnt激活其信号转导受体的能力。我们的初步研究发现，24株胰腺腺癌细胞系中有23株表达SULF1或sul2转录物，其中4/4的胰腺腺癌细胞系和3/5的胰腺肿瘤样本中存在sul1或sul2蛋白。在这4个品系中的3个品系中，显性阴性形式（酶失活突变体）Sulf-1或Sulf-2的表达导致Wnt信号的减少。此外，在无活性硫蛋白存在下共培养相同的三种细胞系，在体外产生Wnt信号传导和细胞生长的平行减少。拟议的研究将采用慢病毒转导shRNA表达来沉默代表性胰腺腺癌细胞系中的一种或两种Sulfs。我们的目标是：1)在体外研究硫沉默对这些细胞生长和Wnt信号传导的影响；2)确定硫沉默对裸鼠细胞形成肿瘤能力的影响。这些研究的积极结果应该会激发人们对Sulfs作为治疗人类胰腺腺癌的可能靶点（小分子或功能阻断抗体）的极大兴趣。